Literature DB >> 9223736

Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients.

K R Fowke1, R D'Amico, D N Chernoff, J C Pottage, C A Benson, B E Sha, H A Kessler, A L Landay, G M Shearer.   

Abstract

OBJECTIVE: The present study was designed to determine the effect of immune activation, achieved by influenza vaccination, on plasma HIV RNA levels and immunological parameters including CD4 cell levels, antigen-stimulated T-cell function and apoptotic death of peripheral blood mononuclear cells. DESIGN AND METHODS: Thirty-four HIV-infected individuals and nine uninfected controls were immunized with influenza vaccine and blood was collected at weeks 0, 2, 4 and 16. Plasma was isolated and used for HIV RNA and influenza-specific antibody qualifications. CD4 cell counts, activation and maturation markers of T-lymphocyte subsets were determined by flow cytometry. In vitro T-helper responses, spontaneous- and activation-induced cell death assays were also performed.
RESULTS: Influenza-specific humoral and cellular immune responses correlated with CD4 count. Only in patients with CD4 counts > 300 x 10(6)/l there was a modest increase in T-cell responses to influenza virus, which was less than control subjects, observed after vaccination. Immunization had no significant effect on CD4 counts or plasma viral levels in the HIV-positive patients. Baseline apoptosis inversely correlated with CD4 counts and directly correlated with viral load. Activation-induced apoptosis did not change appreciably after vaccination and spontaneous apoptosis increased only in the < 300 CD4 group.
CONCLUSION: These results indicate that immune stimulation resulting from influenza vaccination did not significantly change the levels of plasma virus, CD4 cell counts, or activation-induced apoptosis in HIV-infected individuals, although an increase in the T-cell response to influenza and spontaneous apoptosis was observed in the > 300 and < 300 CD4 groups, respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223736     DOI: 10.1097/00002030-199708000-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  20 in total

Review 1.  Monitoring patients with HIV disease.

Authors:  M Helbert; J Breuer
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

Review 2.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

3.  Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation.

Authors:  L A Pinto; V Blazevic; B K Patterson; C Mac Trubey; M J Dolan; G M Shearer
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Analysis of protective immune responses to seasonal influenza vaccination in HIV-infected individuals.

Authors:  Ying Xia; Fuli Mi; Guoqiang Du; Shenghui Qin
Journal:  Hum Vaccin Immunother       Date:  2020-05-15       Impact factor: 3.452

5.  Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals.

Authors:  C A Benne; F P Kroon; M Harmsen; L Tavares; C A Kraaijeveld; J C De Jong
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

6.  Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults.

Authors:  Nancy F Crum-Cianflone; Lynn E Eberly; Chris Duplessis; Jason Maguire; Anuradha Ganesan; Dennis Faix; Gabriel Defang; Yun Bai; Erik Iverson; Tahaniyat Lalani; Timothy Whitman; Patrick J Blair; Carolyn Brandt; Grace Macalino; Timothy Burgess
Journal:  Clin Infect Dis       Date:  2010-12-07       Impact factor: 9.079

7.  Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability.

Authors:  Keri N Althoff; Maryna Eichelberger; Stephen J Gange; Gerald B Sharp; Jin Gao; Marshall J Glesby; Mary Young; Ruth M Greenblatt; Audrey L French; Maria C Villacres; Howard Minkoff
Journal:  AIDS       Date:  2011-06-01       Impact factor: 4.177

Review 8.  Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.

Authors:  Adriano Boasso; Gene M Shearer
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

9.  Standard vaccines increase HIV-1 transcription during antiretroviral therapy.

Authors:  Christina Yek; Sara Gianella; Montserrat Plana; Pedro Castro; Konrad Scheffler; Felipe García; Marta Massanella; Davey M Smith
Journal:  AIDS       Date:  2016-09-24       Impact factor: 4.177

10.  Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis.

Authors:  James D Heffelfinger; Pragna Patel; John T Brooks; Helene Calvet; Charles L Daley; Hazel D Dean; Brian R Edlin; Kathleen F Gensheimer; John Jereb; Charlotte K Kent; Jeffrey L Lennox; Janice K Louie; Ruth Lynfield; Philip J Peters; Lauretta Pinckney; Philip Spradling; Andrew C Voetsch; Anthony Fiore
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.